Antipsychotropic Drugs

Trusted pharma products in Antipsychotropic Drugs

Hydroxyzine Tablets/Capsules

Strength: 10 mg, 25 mg, 50 mg, 100 mg

Form: Tablets/Capsules

Reference Brands: US: Vistaril®, , Atarax®; EU: Atarax®, Hydroxyzine Mylan®, Ucerax®

View Details Get Enquiry

Iloperidone Tablets

Strength: 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg

Form: Tablets

Reference Brands: Fanapt®(US)

View Details Get Enquiry

Imipramine HCl ER capsules

Strength: 75 mg, 100 mg, 125 mg, 150 mg

Form: Capsules (Extended-Release)

Reference Brands: Tofranil-PM® (US)

View Details Get Enquiry

Imipramine Hcl Tablets

Strength: 10 mg, 25 mg, 50 mg

Form: Tablets

Reference Brands: Tofranil®(EU & US)

View Details Get Enquiry

Isocarboxazid Tablets

Strength: 10 mg

Form: Tablets

Reference Brands: Marplan®(US)

View Details Get Enquiry

Levetiracetam Injection (IV)

Strength: 100 mg/mL

Form: Injection (IV)

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

View Details Get Enquiry

Levetiracetam Oral solution

Strength: 100 mg/mL

Form: Oral solution

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

View Details Get Enquiry

Levetiracetam Tablet

Strength: 250mg/500mg/750mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Levetiracetam Tablets

Strength: 250 mg, 500 mg, 750 mg, 1000 mg

Form: Tablets

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

View Details Get Enquiry

Levodopa + Carbidopa

Strength: IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg

Form: Tablets

Reference Brands: Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®

View Details Get Enquiry

Levodopa Carbidopa Tablets

Strength: 110mg,125mg,275mg

Form: Tablets

Reference Brands:

View Details Get Enquiry

Levomilnacipran Extended-Release Capsules

Strength: 20 mg, 40 mg, 80 mg, 120 mg

Form: Extended-Release Capsules

Reference Brands: Fetzima®(US)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.